Influenza-specific immunity in humans is unique because there are repeated exposures to viral strains containing genetically conserved epitopes recruiting memory CD4 T cells and novel epitopes stimulating naive CD4 T cells, possibly resulting in competition between memory and naive lymphocytes. In this study, we evaluated the effect of this competition on CD4 T cell and B cell response specificity using a murine model of sequential influenza infection. We found striking and selective decreases in CD4 T cell reactivity to nonconserved hemagglutinin (HA) epitopes following secondary influenza infection. Surprisingly, this shift in CD4 T cell specificity was associated with dramatic decreases in HA-specific Ab. These results suggest that repeated exposure to influenza viruses and vaccines containing conserved internal proteins may have unintended and negative consequences on the ability to induce HA-specific Ab to novel pandemic strains of influenza. These finding could have important implications on pandemic influenza preparedness strategies.

Influenza-specific immunity offers unique challenges to the human host because of frequent changes in the immunogen over time. Ab-mediated immune pressure leads to emergence of immunological escape variants that circulate in the population, which in turn necessitates formulation and administration of vaccines derived from new viral strains. Also, periodically, completely novel strains with pandemic potential arise owing to recombination between two viruses. Thus, both natural infection and yearly vaccination result in exposure to novel epitopes that elicit a naive T cell response and genetically conserved determinants that stimulate memory T cells. How this competition among memory and naive T cells influences the specificity and functionality of the protective immune response is poorly understood.

Although there is substantial literature describing the specificity of the primary T cell response to influenza (15), there have been relatively few studies examining how the primary T cell repertoire is remodeled with even a single subsequent encounter with a strain of influenza that shares some, but not all, of its T cell epitopes with the first virus. It is known that the CD8 T cell immunodominance hierarchy can shift following a secondary infection (6), in part as a result of differential Ag presentation (7). However, the duration of Ag presentation may also be decreased following a secondary infection, possibly due to destruction of APCs by cytotoxic memory CD8 T cells (810). Although memory and naive CD8 T cells have been found to expand concurrently in response to influenza infection (11), how repeat encounters with heterosubtypic strains of influenza virus shape the specificity of the CD4 T cell response against this virus has not yet been evaluated.

In this study, we have used a murine model of sequential influenza infection to examine the specificity of CD4 T cell and Ab responses following heterosubtypic infection. We found that, as expected, a secondary infection boosted responses to genetically conserved epitopes. Strikingly, this boost was accompanied by a dramatic suppression of CD4 T cell responses directed against novel influenza epitopes contained in the challenge virus. Most surprisingly, the shift in CD4 T cell specificity toward conserved internal virion proteins was associated with a decrease in hemagglutinin (HA)-specific Ab. These results suggest that periodic natural infections with influenza and the yearly administration of inactivated influenza vaccines containing internal virion proteins (1214) could have unexpected deleterious consequences on the production of neutralizing Ab following exposure to a novel influenza strain.

C57BL/10J mice (B10; H-2b) were purchased from The Jackson Laboratory (Bar Harbor, ME). B10.S-H2S/SgMcdJ mice (B10.S; H-2s) were purchased from The Jackson Laboratory and bred at the University of Rochester. Animals were housed in specific pathogen-free facilities and maintained according to institutional guidelines. Studies were performed in compliance with the United States Department of Health and Human Services Guide for the Care and Use of Laboratory Animals. Animal use protocols were approved by the University of Rochester Committee on Animal Resources (Animal Welfare Assurance no. A3291-01).

Peptides (17-mer) previously identified as I-Ab– or I-As–restricted influenza epitopes (2) were obtained through the National Institutes of Health Biodefense and Emerging Infections Research Resources Repository (National Institute of Allergy and Infectious Diseases) or synthesized in our facility using an Apex 396 system (AAPPTec, Louisville, KY) as described previously (15). Peptides used as Ag for restimulation are shown in Supplemental Table I (I-Ab) and Supplemental Table II (I-As), with the x139 sequence above and the X-31 sequences below. Individual peptides were used at a final concentration of 10 μM.

X-31 influenza virus was provided by Dr. David Topham at the University of Rochester, and x139 influenza virus was provided by Dr. Doris Bucher at New York Medical College. Mice were anesthetized by i.p. injection of tribromoethanol and were infected intranasally with 30 μl of X-31 in PBS at a dose of 300,000 fifty percent egg-infectious dose per mouse. After 8–9 wk, mice were infected intranasally with x139 influenza at a dose of 50,000 fifty percent egg-infectious dose per mouse. After infection, spleens and mediastinal lymph nodes (MLNs) were excised and used as a source of CD4 T cells for ELISPOT analysis. Syngeneic splenocytes from uninfected mice were used as APCs.

IFN-γ ELISPOT assays were performed as previously described (2). Briefly, CD4 T cells were enriched from splenocytes either by Ab and complement (2) or by negative selection using MACS no-touch CD4 purification (Miltenyi Biotec, Gladbach, Germany) per the manufacturer’s instructions. Individual MLNs were used undepleted. The plates were processed and analyzed as previously described (2). Data were calculated and presented as cytokine ELISPOTs per million CD4 T cells with background values subtracted (typically <20 spots/well), and MLN results were normalized to account for the percentage of CD4 T cells as determined by analytical flow cytometry.

Sera were treated with receptor-destroying enzyme (Denka Seiken, Tokyo, Japan) per the manufacturer’s protocol and heat-inactivated prior to testing as previously described (15). The microneutralization titers were defined as the reciprocal of the highest serum dilution at which all of the culture wells were negative for cytopathic effect.

CD8 Ab (clone 2.43; Bio X Cell, West Lebanon, NH) was used for in vivo depletion of CD8 T cells. Two hundred micrograms of anti-CD8 or isotype control IgG2b (Bio X Cell) Abs was injected i.p. every other day beginning 2 d prior to infection. At 8 d after infection, the mice were euthanized and tissues and blood were harvested for ELISPOT assay.

Analytical flow cytometry was performed by staining with CD4-FITC (clone RM4-4; BD Biosciences) and CD8a-FITC (Ly-2 clone 53-6.7; eBioscience, San Diego, CA) or CD8b-FITC (H35-17.2; eBioscience). Data were analyzed using CellQuest software (Becton Dickinson).

Blood was collected from individual mice and the presence of HA- and nuclear protein (NP)–specific Abs in serum was determined using ELISA assays as previously described (15), using either 250 ng/100 μl recombinant A/New Caledonia/20/99 HA protein (Protein Sciences, Meriden, CT) or 200 ng/μl recombinant A/New Caledonia/20/99 NP protein produced in-house using an Escherichia coli expression system (15). After incubation with diluted serum, the plates were washed and developed as previously described (15).

It is known that naive and memory CD4 T cells differ with regard to their gene expression patterns and their sensitivity to Ag (16, 17), but how these differences influence competitive immune responses as occur following heterosubtypic influenza infection has not been explored. To rigorously address this issue, we used an animal model of sequential infection. Mice were initially infected with X-31, a recombinant influenza virus containing the HA and neuraminidase (NA) proteins of A/Aichi/2/68 (H3N2), with all other proteins derived from A/Puerto Rico/8/34 (H1N1). After waiting 8–9 wk to establish memory, mice were infected with a reassortant virus (x139) composed of the HA, NA, NP, and polymerase basic 1 proteins of A/New Caledonia/20/99 virus (H1N1) with all other proteins derived from X-31. This combination of viruses thus has unrelated HA and NA proteins whereas most internal viral proteins remain conserved. At various time points after infection, CD4 T cell responses were directly compared between secondary and primary x139 infections using IFN-γ ELISPOT assays. CD4 T cell specificity was assessed using known I-Ab– and I-As–restricted influenza peptides from the HA, NA, NP, M1, PA, and polymerase basic 1 proteins (2). Mice infected with X-31 8–9 wk prior served as a control for waning CD4 T cell immunity.

Our initial experiments revealed that CD4 T cell responses directed against conserved epitopes were maintained or boosted following a secondary heterosubtypic influenza infection (Fig. 1A, 1B). Additionally, and quite unexpectedly, responses to specificities unique to the new challenge virus were greatly diminished throughout the duration of the response compared with responses following a primary infection (Fig. 1C, 1D). The suppression affected multiple HA epitopes in both the B10.S (Fig. 1C) and B10 (Fig. 1D) mouse strains, persisted through all time points tested, and was present in both the spleen and the draining MLN (data not shown). Collectively, these data suggest that following secondary infection with a viral strain containing both conserved and highly divergent epitopes, new specificities contributed by naive cells are at a significant disadvantage compared with responding memory CD4 T cells devoted to the more conserved peptide epitopes.

FIGURE 1.

CD4 T cell reactivity to nonconserved epitopes is selectively diminished following a secondary heterosubtypic influenza infection. B10.S and B10 mice were infected sequentially with X-31 (H3N2) followed by x139 (H1N1) influenza or were only infected with x139 influenza. CD4 T cells were isolated from the spleen and ELISPOT assays were performed using I-As– and I-Ab–restricted peptide epitopes as restimulation Ags. The top panels depict reactivity to conserved epitopes in B10.S (A) and B10 (B) mice at day 4 (left panels) and day 7 or 8 (right panels) following infection. (C) CD4 T cell reactivity to nonconserved epitopes in B10.S mice. Each time point represents data from five to nine individual mice. (D) Reactivity to nonconserved epitopes in B10 mice over time; each time point shows the average of three individual mice. *p < 0.05 using Welch t test when comparing the secondary to the primary infection.

FIGURE 1.

CD4 T cell reactivity to nonconserved epitopes is selectively diminished following a secondary heterosubtypic influenza infection. B10.S and B10 mice were infected sequentially with X-31 (H3N2) followed by x139 (H1N1) influenza or were only infected with x139 influenza. CD4 T cells were isolated from the spleen and ELISPOT assays were performed using I-As– and I-Ab–restricted peptide epitopes as restimulation Ags. The top panels depict reactivity to conserved epitopes in B10.S (A) and B10 (B) mice at day 4 (left panels) and day 7 or 8 (right panels) following infection. (C) CD4 T cell reactivity to nonconserved epitopes in B10.S mice. Each time point represents data from five to nine individual mice. (D) Reactivity to nonconserved epitopes in B10 mice over time; each time point shows the average of three individual mice. *p < 0.05 using Welch t test when comparing the secondary to the primary infection.

Close modal

We next sought to determine whether this change in CD4 T cell specificity is associated with any changes in Ab specificity or kinetics. The issue of a linkage between CD4 T cell and B cell specificities is somewhat controversial (14, 1820). Such a linkage could occur because under physiologic conditions Ag-specific B cells predominantly internalize Ag through their BCR (21) and thus, depending on the source of Ag available, not all virion proteins may be equally internalized by virus-specific B cells. This restricted Ag uptake could favor the presentation of HA-derived epitopes by HA-specific B cells and result in the selective recruitment of help from HA-specific CD4 T cells. ELISA assays were used to compare reactivity against the A/New Caledonia HA and NP proteins expressed in the challenge strain following a primary or secondary heterosubtypic infection. Unexpectedly, we found markedly diminished HA-specific Ab titers at days 7 and 11 following secondary infection (Fig. 2A, 2B) that contrasted with accelerated kinetics of NP-specific Ab production (Fig. 2C). This pattern was maintained when neutralizing Ab titers to HA were tested using a microneutralization assay (Fig. 2D). These data reveal a linkage between CD4 T cell and B cell specificities and suggest that HA-specific CD4 T cells may be better able to help in the production of high-affinity neutralizing Ab. Taken together, these studies suggest that CD4 T cell specificity following primary infection is substantially remodeled following secondary infection and that this change is associated with a dramatic shift in Ab specificity.

FIGURE 2.

Heterosubtypic infection is associated with a decrease in HA-specific Ab. HA- (A, B) and NP-specific (C) ELISA assays were performed on serum obtained from B10.S mice following primary and secondary influenza infection (open and closed circles, respectively). Serum from mice infected with X-31 8–9 wk prior and from naive mice served as controls (open and closed triangles, respectively). Each point represents the average of sera from four to nine individual mice (experimental groups) or two to five individual mice (control groups). Error bars depict the SEM. (D) Results of a microneutralization assay performed on sera obtained from individual B10.S mice at 22 d after infection. Horizontal lines show the geometric mean of each group. A one-way ANOVA with a Bonferroni multiple comparison test was used to compare groups, with asterisks denoting p values < 0.05.

FIGURE 2.

Heterosubtypic infection is associated with a decrease in HA-specific Ab. HA- (A, B) and NP-specific (C) ELISA assays were performed on serum obtained from B10.S mice following primary and secondary influenza infection (open and closed circles, respectively). Serum from mice infected with X-31 8–9 wk prior and from naive mice served as controls (open and closed triangles, respectively). Each point represents the average of sera from four to nine individual mice (experimental groups) or two to five individual mice (control groups). Error bars depict the SEM. (D) Results of a microneutralization assay performed on sera obtained from individual B10.S mice at 22 d after infection. Horizontal lines show the geometric mean of each group. A one-way ANOVA with a Bonferroni multiple comparison test was used to compare groups, with asterisks denoting p values < 0.05.

Close modal

There are several possible mechanisms that may act alone or together during a heterosubtypic viral infection to account for these findings. One possibility to explain the shifts in CD4 T cell specificity is that the cytolytic activity of memory CD8 T cells decreases the duration of Ag presentation (8, 10, 22), selectively inhibiting the expansion of naive CD4 T cells. This possibility was investigated by selective depletion of CD8 T cells prior to and throughout the duration of the secondary infection. This procedure had only minor effects on the HA-specific suppression of CD4 T cells (Fig. 3), suggesting that CD8 T cell activity does not have a major role in the suppression of responses seen.

FIGURE 3.

CD8 depletion has a modest effect on CD4 T cell reactivity to nonconserved HA epitopes. B10 CD8 T cells were depleted in vivo throughout the duration of secondary infection (days −2, 0, 2, 4, and 6). Eight days after infection, CD4 T cell reactivity to various epitopes was examined by IFN-γ ELISPOT assay. (A) Data obtained from MACS-purified CD4 T cells isolated from the spleen. (B) IFN-γ ELISPOTs obtained from unpurified MLN cells. Data are presented as spots per 106 CD4 T cells, with MLN data normalized for the percentage of CD4 T cells present. Flow cytometric analysis of both spleen and MLN cells indicated complete depletion of CD8 T cells.

FIGURE 3.

CD8 depletion has a modest effect on CD4 T cell reactivity to nonconserved HA epitopes. B10 CD8 T cells were depleted in vivo throughout the duration of secondary infection (days −2, 0, 2, 4, and 6). Eight days after infection, CD4 T cell reactivity to various epitopes was examined by IFN-γ ELISPOT assay. (A) Data obtained from MACS-purified CD4 T cells isolated from the spleen. (B) IFN-γ ELISPOTs obtained from unpurified MLN cells. Data are presented as spots per 106 CD4 T cells, with MLN data normalized for the percentage of CD4 T cells present. Flow cytometric analysis of both spleen and MLN cells indicated complete depletion of CD8 T cells.

Close modal

Another possibility is that the B cells primed during the primary infection are directly perturbing the secondary infection, either through cross-reactive neutralizing Ab or via the phenomenon of original antigenic sin. Original antigenic sin has been described to occur following sequential infection with closely related influenza variants. In this situation, infection with a second, related strain induces a preferential Ab response to the first viral strain encountered, with a resulting decrease in the Ab response to the newly infecting strain (23, 24). In our model of heterosubtypic infection, the infecting strains contain highly divergent HA molecules from different HA groups (X-31, H3; x139, H1) that did not induce detectable levels of cross-reactive Ab by either ELISA (Fig. 2A, 2B) or microneutralization assay (Fig. 2D). This argues against a role for cross-reactive neutralizing Ab in either decreasing the viral load or causing original antigenic sin. Additionally, boosting of the Ab response to X-31 was not seen when X-31–neutralizing Ab titers were compared by microneutralization assay in mice infected with X-31 alone or following a secondary infection with x139 (Fig. 4). Thus, our findings do not appear to be consistent with original antigenic sin.

FIGURE 4.

Neutralizing Ab against X-31 influenza (H3N2) is not boosted following secondary infection with x139 (H1N1). At 22 d after infection, sera from three to six individual mice per experimental group were assayed for Ab against X-31 influenza virus by an in vitro microneutralization assay, as described in 2Materials and Methods. Data are depicted as the geometric mean, with error bars representing the 95% confidence interval.

FIGURE 4.

Neutralizing Ab against X-31 influenza (H3N2) is not boosted following secondary infection with x139 (H1N1). At 22 d after infection, sera from three to six individual mice per experimental group were assayed for Ab against X-31 influenza virus by an in vitro microneutralization assay, as described in 2Materials and Methods. Data are depicted as the geometric mean, with error bars representing the 95% confidence interval.

Close modal

Collectively, these data suggest that CD4 T cells were responsible for the shifts in specificity following confrontation of the host with a novel influenza strain. This could either be the result of regulatory CD4 T cells (25) or through independent effector mechanism that result in faster viral clearance (26, 27). Current experiments are designed to evaluate these possibilities more fully. Independent of the mechanisms responsible for the loss in HA-specific CD4 T cell responses, the coordinate shift in Ab response could reflect a linkage between CD4 T cell and B cell specificities. Future experiments will be able to further address the mechanism behind the shift away from HA in both CD4 T cells and B cells following rechallenge with heterosubtypic strains of influenza.

It is interesting to consider these results with respect to pandemic influenza preparedness strategies. Most clinically available inactivated influenza vaccines, including vaccines directed against pandemic strains, contain conserved internal proteins that are able to stimulate an immune response (Refs. 1214 and unpublished data). Our data suggests that simultaneous boosting of CD4 T cells specific for conserved internal proteins will result in less robust HA-specific CD4 T cell responses and concurrent lower titers of neutralizing Abs on challenge with vaccines containing highly divergent HA proteins with few conserved HA epitopes. This could in part explain the modest responses seen following a single dose of many pandemic vaccines, including against the avian H5 (28) and H7 (29, 30) strains. To promote pandemic preparedness, vaccination with highly purified avian HA molecules that promote the development of memory CD4 T cells specific for HA-specific epitopes may allow more rapid and robust Ab responses to the next pandemic strain, regardless of whether serological cross-reactivity is present.

We thank Dr. Doris Bucher at New York Medical College for the x139 virus and Dr. David Topham at the University of Rochester for the X-31 virus.

This work was supported by National Institutes of Health Contract HHSN266200700008C and by National Institutes of Health Grant 1K12HD068373-01.

The online version of this article contains supplemental material.

Abbreviations used in this article:

B10

C57BL/10J

B10.S

B10.S-H2S/SgMcdJ

HA

hemagglutinin

MLN

mediastinal lymph node

NA

neuraminidase

NP

nuclear protein.

1
Richards
K. A.
,
Chaves
F. A.
,
Sant
A. J.
.
2009
.
Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.
J. Virol.
83
:
6566
6577
.
2
Nayak
J. L.
,
Richards
K. A.
,
Chaves
F. A.
,
Sant
A. J.
.
2010
.
Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins.
Viral Immunol.
23
:
169
180
.
3
Crowe
S. R.
,
Miller
S. C.
,
Brown
D. M.
,
Adams
P. S.
,
Dutton
R. W.
,
Harmsen
A. G.
,
Lund
F. E.
,
Randall
T. D.
,
Swain
S. L.
,
Woodland
D. L.
.
2006
.
Uneven distribution of MHC class II epitopes within the influenza virus.
Vaccine
24
:
457
467
.
4
Belz
G. T.
,
Stevenson
P. G.
,
Doherty
P. C.
.
2000
.
Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses.
J. Immunol.
165
:
2404
2409
.
5
Zhong
W.
,
Reche
P. A.
,
Lai
C.-C.
,
Reinhold
B.
,
Reinherz
E. L.
.
2003
.
Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire.
J. Biol. Chem.
278
:
45135
45144
.
6
Belz
G. T.
,
Xie
W.
,
Altman
J. D.
,
Doherty
P. C.
.
2000
.
A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge.
J. Virol.
74
:
3486
3493
.
7
Crowe
S. R.
,
Turner
S. J.
,
Miller
S. C.
,
Roberts
A. D.
,
Rappolo
R. A.
,
Doherty
P. C.
,
Ely
K. H.
,
Woodland
D. L.
.
2003
.
Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections.
J. Exp. Med.
198
:
399
410
.
8
Yang
J.
,
Huck
S. P.
,
McHugh
R. S.
,
Hermans
I. F.
,
Ronchese
F.
.
2006
.
Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.
Proc. Natl. Acad. Sci. USA
103
:
147
152
.
9
Mintern
J. D.
,
Bedoui
S.
,
Davey
G. M.
,
Moffat
J. M.
,
Doherty
P. C.
,
Turner
S. J.
.
2009
.
Transience of MHC class I-restricted antigen presentation after influenza A virus infection.
Proc. Natl. Acad. Sci. USA
106
:
6724
6729
.
10
Belz
G. T.
,
Zhang
L.
,
Lay
M. D.
,
Kupresanin
F.
,
Davenport
M. P.
.
2007
.
Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell.
Proc. Natl. Acad. Sci. USA
104
:
6341
6346
.
11
Turner
S. J.
,
Cross
R.
,
Xie
W.
,
Doherty
P. C.
.
2001
.
Concurrent naive and memory CD8+ T cell responses to an influenza A virus.
J. Immunol.
167
:
2753
2758
.
12
Co
M. D.
,
Orphin
L.
,
Cruz
J.
,
Pazoles
P.
,
Green
K. M.
,
Potts
J.
,
Leporati
A. M.
,
Babon
J. A.
,
Evans
J. E.
,
Ennis
F. A.
,
Terajima
M.
.
2009
.
In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.
Vaccine
27
:
319
327
.
13
Richards
K. A.
,
Chaves
F. A.
,
Alam
S.
,
Sant
A. J.
.
2012
.
Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.
Vaccine
31
:
219
225
.
14
Nayak
J. L.
,
Fitzgerald
T. F.
,
Richards
K. A.
,
Yang
H.
,
Treanor
J. J.
,
Sant
A. J.
.
2013
.
CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) influenza subtype H1N1 vaccine.
J. Infect. Dis.
207
:
297
305
15
Alam
S.
,
Sant
A. J.
.
2011
.
Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
J. Virol.
85
:
13310
13321
.
16
MacLeod
M. K.
,
Kappler
J. W.
,
Marrack
P.
.
2010
.
Memory CD4 T cells: generation, reactivation and re-assignment.
Immunology
130
:
10
15
.
17
McKinstry
K. K.
,
Strutt
T. M.
,
Swain
S. L.
.
2010
.
The potential of CD4 T-cell memory.
Immunology
130
:
1
9
.
18
Sette
A.
,
Moutaftsi
M.
,
Moyron-Quiroz
J.
,
McCausland
M. M.
,
Davies
D. H.
,
Johnston
R. J.
,
Peters
B.
,
Rafii-El-Idrissi Benhnia
M.
,
Hoffmann
J.
,
Su
H. P.
, et al
.
2008
.
Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.
Immunity
28
:
847
858
.
19
Scherle
P. A.
,
Gerhard
W.
.
1988
.
Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.
Proc. Natl. Acad. Sci. USA
85
:
4446
4450
.
20
Johansson
B. E.
,
Moran
T. M.
,
Kilbourne
E. D.
.
1987
.
Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.
Proc. Natl. Acad. Sci. USA
84
:
6869
6873
.
21
Lanzavecchia
A.
1990
.
Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes.
Annu. Rev. Immunol.
8
:
773
793
.
22
Ravkov
E. V.
,
Williams
M. A.
.
2009
.
The magnitude of CD4+ T cell recall responses is controlled by the duration of the secondary stimulus.
J. Immunol.
183
:
2382
2389
.
23
Fazekas de St. Groth
S.
,
Webster
R. G.
.
1966
.
Disquisitions of original antigenic sin. I. Evidence in man.
J. Exp. Med.
124
:
331
345
.
24
Kim
J. H.
,
Skountzou
I.
,
Compans
R.
,
Jacob
J.
.
2009
.
Original antigenic sin responses to influenza viruses.
J. Immunol.
183
:
3294
3301
.
25
Sanchez
A. M.
,
Zhu
J.
,
Huang
X.
,
Yang
Y.
.
2012
.
The development and function of memory regulatory T cells after acute viral infections.
J. Immunol.
189
:
2805
2814
.
26
Teijaro
J. R.
,
Verhoeven
D.
,
Page
C. A.
,
Turner
D.
,
Farber
D. L.
.
2010
.
Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.
J. Virol.
84
:
9217
9226
.
27
Strutt
T. M.
,
McKinstry
K. K.
,
Dibble
J. P.
,
Winchell
C.
,
Kuang
Y.
,
Curtis
J. D.
,
Huston
G.
,
Dutton
R. W.
,
Swain
S. L.
.
2010
.
Memory CD4+ T cells induce innate responses independently of pathogen.
Nat. Med.
16
:
558
564
.
28
Treanor
J. J.
,
Campbell
J. D.
,
Zangwill
K. M.
,
Rowe
T.
,
Wolff
M.
.
2006
.
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
N. Engl. J. Med.
354
:
1343
1351
.
29
Cox
R. J.
,
Madhun
A. S.
,
Hauge
S.
,
Sjursen
H.
,
Major
D.
,
Kuhne
M.
,
Höschler
K.
,
Saville
M.
,
Vogel
F. R.
,
Barclay
W.
, et al
.
2009
.
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
Vaccine
27
:
1889
1897
.
30
Couch
R. B.
,
Patel
S. M.
,
Wade-Bowers
C. L.
,
Niño
D.
.
2012
.
A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.
PLoS ONE
7
:
e49704
.

The authors have no financial conflicts of interest.